The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
GMO Pepabo Inc
TSE:3633
|
JP |
|
Oil-Dri Corporation of America
NYSE:ODC
|
US |
|
T
|
Takeda Pharmaceutical Co Ltd
F:TKDA
|
JP |
|
Agilysys Inc
NASDAQ:AGYS
|
US |
|
S
|
Stef SA
F:STP
|
FR |
|
S
|
Symtek Automation Asia Co Ltd
TWSE:6438
|
TW |
|
R
|
RWE AG
F:RWEA
|
DE |
|
Nomura Holdings Inc
NYSE:NMR
|
JP |
|
SCE Intelligent Commercial Management Holdings Ltd
HKEX:606
|
CN |
|
Covivio SA
F:F5D
|
FR |
|
C
|
Cisco Systems Inc
XHAM:CIS
|
US |
|
A
|
Akamai Technologies Inc
XMUN:AK3
|
US |
|
Celsius Holdings Inc
NASDAQ:CELH
|
US |
|
A
|
Administer Oy
OMXH:ADMIN
|
FI |
|
N
|
Northrop Grumman Corp
DUS:NTH
|
US |
|
A
|
Avis Budget Group Inc
BMV:CAR
|
US |
|
Opthea Ltd
ASX:CYV
|
AU |
|
US Global Investors Inc
NASDAQ:GROW
|
US |
|
V
|
VICI Properties Inc
F:1KN
|
US |
|
K
|
Kerry Group PLC
OTC:KRYAF
|
IE |
|
Casta Diva Group SpA
F:99C
|
IT |
|
B
|
Brookside Energy Ltd
F:8F3
|
AU |
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
GMO Pepabo Inc does not have any price targets made by Wall Street professionals.
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 2 years is 1%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 5%. The projected CAGR for the next 2 years is 0%.
Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 2 years is 0%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more